Expression of cyclooxygenase-2 and matrix metalloproteinase-2 in adenomyosis and endometrial polyps and its correlation with angiogenesis

International Journal of Gynecological Pathology

Volumn 28, Issue 2, 2009, Pages 148-156

  Tokyol, Cigdem ^a,b   Aktepe, Fatma ^a   Dilek, Fatma Hüsniye ^a   Sahin, Onder ^a   Arioz, Dagistan Tolga ^a  

^a AFYON KOCATEPE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b AFYON KOCATEPE UNIVERSITY   (Turkey)

Author keywords

Adenomyosis; Cyclooxgenase 2; Endometrial polyps; Matrix metalloproteinase 2; Microvessel density

Indexed keywords

CD34 ANTIGEN; CYCLOOXYGENASE 2; GELATINASE A;

ADENOMYOSIS; ADULT; ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM POLYP; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MICROVASCULATURE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; VASCULAR ENDOTHELIUM;

ADULT; ANTIGENS, CD34; CYCLOOXYGENASE 2; ENDOMETRIOSIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; POLYPS; UTERINE DISEASES;

EID: 68349136521     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/PGP.0b013e318187033b     Document Type: Article

References (39)

1. Kumar V, Abbas AK, Fausto N. Acute and chronic inflammation. In: Kumar A, Abbas AK, Fausto N, eds. Robbins Pathologic Basis of Disease. 7th ed. China: Elsevier Saunders; 2005:47-86.
2. Masferrer JL, Zweifel BS, Colburn SM, et al. The role of cyclooxygenase-2 in inflammation. Am J Ther 1995;9:607-610
3. O'Banion MK, Winn VD, Yound DA. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc Natl Acad Sci U S A 1992;89:4888-4892
4. 2 in human colon cancer cells. Cancer Res 1998;58:362-366
5. Dinchuk JE, Car BD, Focht RJ, et al. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 1995;378:406-409
6. Maia H Jr, Maltez A, Studard E, et al. Effect of menstrual cycle and oral contraceptives on cyclooxygenase-2 expression in the endometrium. Gynecol Endocrinol 2005;21:57-61. (Pubitemid 41097797)
7. Bulun SE, Zeitoun KM, Takayama K, et al. Molecular basis for treating endometriosis with aromatase inhibitors. Hum Reprod Update 2000;6:413-418 (Pubitemid 30763279)
8. Maia H Jr, Pimentel K, Silva TM, et al. Aromatase and cyclooxygenase-2 expression in the endometrial polyps during the menstrual cycle. Gynecol Endocrinol. 2006;22:219-224
9. Urabe M, Yamamoto T, Kitawaki J, et al. Estrogen biosynthesis in human uterine adenomyosis. Acta Endocrinol (Copenh) 1989;121:259-264 (Pubitemid 19212172)
10. Kitawaki J, Kusuki I, Koshiba H, et al. Expression of aromatase cytochrome p450 in eutopic endometrium and its application as a diagnostic test for endometriosis. Gynecol Obstet Invest 1999;48(suppl 1):21-28 (Pubitemid 30088796)
11. Noble LS, Takayama K, Zeitoung KM, et al. Prostaglandin E2 stimulates aromatase activity in endometriosis derived stromal cells. J Clin Endocrinol Metab 1997;82:600-606 (Pubitemid 27068636)
12. Bulun SE, Fang Z, Imir G, et al. Aromatase and endometriosis. Semin Reprod Med 2004;22:45-50.
13. Bulun SE, Zeitoun KM, Takayama K, et al. Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance. J Mol Endocrinol 2000;25:35-42. (Pubitemid 30617072)
14. Kim MR, Kim YA, Jo MY, et al. High frequency of endometrial polyps in endometriosis. J Am Assoc Gynecol Laparosc 2003;10:46-48.
15. Tsoboi R, Sato Y, Rifkin DB. Correlation of cell migration, cell invasion, receptor number, proteinase production, and basic fibroblast growth factor levels in endothelial cells. J Cell Biol 1990;110:511-517 (Pubitemid 20067594)
16. Bachmeier BE, Rohrbach H, De Waal J, et al. Enhanced expression and activation of major matrix metalloproteinases in distinct topographic areas of invasive breast carcinomas. Int J Oncol 2005;26:1203-1207
17. Chung HW, Wen Y, Chun SH, et al. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in woman with: endometriosis: a rationale for endometriotic invasiveness. Fertil Steril 2001;75:152-159 (Pubitemid 32041238)
18. Inagaki N, Ung L, Otani T, et al. Uterine cavity matrix metalloproteinases and cytokines in patients with leiomyoma, adenomyosis or endometrial polyp. Eur J Obstet Gynecol Reprod Biol 2003;111:197-203. (Pubitemid 37338741)
19. Leung WK, To KF, Go MY, et al. Cyclooxygenase-2 upregulates vascular endothelial growth factor expression and angiogenesis in human gastric carcinoma. Int J Oncol 2003;23:1317-1322
20. Tsujii M, Kawano S, Tsuji S, et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998;93:705-716 (Pubitemid 28257578)
21. Rundhaug JE. Matrix metalloproteinases and angiogenesis. J Cell Mol Med 2005;9:267-285
22. Maia JR H, Casoy J, Correia T, et al. Effect of the menstrual cycle and oral contraceptives on aromatase and cyclooxygenase-2 expression in adenomyosis. Gynecol Endocrinol 2006;22:547-551 (Pubitemid 44885093)
23. Noyes RW, Hertig AT, Rock JR. Dating the endometrial biopsy. Fertil Steril 1950;1:3-25.
24. Sun WH, Sun YL, Fang RN, et al. Expression of cyclooxygenase-2 and matrix metalloproteinase-9 in gastric carcinoma and its correlation with angiogenesis. Jpn J Clin Oncol 2005;35:707-713. (Pubitemid 43091655)
25. Weidner N, Semple JP, Welch WR, et al. Tumour angiogenesis and metastases - correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
26. Bosari S, Lee AK, DeLellis RA, et al. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 1992;23:755-761
27. Stewart CJ, Campbell-Brown M, Critchley HO, et al. Endometrial apoptosis in patients with dysfunctional uterine bleeding. Histopathology 1999;34:99-105. (Pubitemid 29083209)
28. Ota H, Igarashi S, Sasaki M, et al. Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis. Hum Reprod. 2001;16:561-566 (Pubitemid 32218810)
29. Ito H, Isaka K, Usuda S, et al. Study on the relationship between endometrial invasion and gelatinases (MMP-2, MMP-9) in adenomyosis. Acta Obstet Gynaecol Jpn 2000;52:795-802.
30. Qiu F, Gao XM, Luo GL, et al. Expression of matrix metalloproteinase and tissue inhibitor of metalloproteinase in adenomyosis. Sichuan Da Xue Xue Bao Yi Xue Ban 2006;37:118-122 (Pubitemid 43155957)
31. Eom DW, Kang GH, Park HM, et al. Expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 compared with ER and PR expressions in the endometriosis and adenomyosis. Korean J Obstet Gynecol 2004;47:1965-1974
32. Mori T, Yamasaki S, Masui F, et al. Suppression of the development of experimentally induced uterine adenomyosis by a novel matrix metalloproteinase inhibitor, ONO-4817, in mice. Exp Biol Med 2001;226:429-433 (Pubitemid 32506367)
33. Kang S, Zhao X, Xing H, et al. Polymorphisms in the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 and the risk of human adenomyosis. Environ Mol Mutagen 2008;49:226-231
34. Ota H, Tanaka T. Stromal vascularization in the endometrium during adenomyosis. Microsc Res Tech 2003;60:445-449
35. Ota H. Evaluation of hysteroscopy in the diagnosis of adenomyosis. Jpn J Fertil Steril 1992;37:49-55.
36. Ota H, Igarashi S, Tanaka T. Morphometric evaluation of stromal vascularization in the endometrium in adenomyosis. Hum Reprod 1998;13:715-719 (Pubitemid 28171975)
37. Li T, Li Y-G, Pu D-M. Matrix metalloproteinase-2 and -9 expression correlated with angiogenesis in human adenomyosis. Gynecol Obstet Invest 2006;62:229-235 (Pubitemid 44763191)
38. Maia JR H, Correia T, Freitas LA, et al. Cyclooxygenase-2 expression in endometrial polyps during menopause. Gynecol Endocrinol 2005;21:336-339 (Pubitemid 43068032)
39. Kumar V, Abbas AK, Fausto N. Neoplasia. In: Kumar A, Abbas AK, Fausto N, eds. Robbins Pathologic Basis of Disease. 7th ed. China: Elsevier Saunders; 2005:269-342.